AzTrials
AzTrials

Ovarian NeoplasmsPhase 3NCT05244811

Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills

A Phase 3 study testing Combined Oral Contraceptive and Progestin in people with Ovarian Neoplasms, run by Sohag University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

comparison between cocs and progesterone only containing pills in treatment of fuctional ovarian cyst Read more about this study

Who is it for?
Ages 18 to 48 years, women only
Conditions the study is for
Ovarian Neoplasms
What is being tested?
Combined Oral Contraceptive and Progestin
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
No sites listed yet
Study dates
20 Feb 2022to Jan 2023
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 48 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • The current randomized, clinical trial was performed on females with:-
  • functional ovarian cysts (4 to 8 cm in diameter)
  • in reproductive age, within the age range of 18 to 48 years, referred to the Clinic of Gynecological Diseases in a private hospital as outpatient The cysts were identified by transvaginal ultrasonography

Who cannot join

  • were history of:-
  • endometrioma.
  • Other non-functional .ovarian neoplasm
  • OCPs consumption during the last three months The patients were randomly divided into three equals

Trial locations and contacts

No sites are listed yet.

salah mohamed rasheed, professor contact

01224653702

salahrasheed67@yahoo.com

mamdouh elsemary aaied, dr contact

01062342515

About this study

Official title: Treatment of Functional Ovarian Cyst Randomised Clinical Trial

comparison between cocs and progesterone only containing pills in treatment of fuctional ovarian cyst

Read the detailed description

Ovarian cyst is a blister-like sac, which is formed on the surface of ovary during or after ovulation . Most of them are made in reproductive age and are harmless ; these cysts do not cause any symptom and are resolved without treatment , but sometimes they cause health problems that require special attention, and even may lead to infertility. Normal function of ovary is the periodic release of ovums and the production of the steroid hormones of estradiol and progesterone . Both activities are integrated in the continuous repetitive process of follicle maturation, ovulation, and corpus luteum formation and regression. Mature follicle is ruptured and releases ovum during ovulation and corpus luteum is produced from empty follicle if pregnancy does not occur corpus luteum is regressed, due to the absence of hCG (human chorionic gonadotropin). Sometimes this procedure does not happen normally, which results in the formation of ovarian cysts Therefore, functional ovarian cysts are different from ovarian growths induced by other pathological problems most of them regress spontaneously in two or three cycles , but if a cyst gets large, it can twist, be ruptured, or bleed and become very painful .

A functional type of ovarian cyst forms because of slight changes in the way of making or releasing an ovum by the ovary . There are two types of such cysts:

  1. The follicular cyst, which occurs when the sac on ovary does not release an egg and the sac swells up with fluid
  2. The luteal cyst, which is formed when the sac releases an egg and then reseals and fills with fluid

Most functional ovarian cysts are asymptomatic , the larger the cyst, the more likely the symptom. The symptoms are pain or aching in lower abdomen, menstrual irregularity, vaginal bleeding, dyspareunia, etc.; sometimes the cyst is ruptured and causes peritoneal irritation with presentations such as nausea and vomiting or sudden onset of pain, hemorrhagic cyst, intra-abdominal bleeding, and emergency conditions . Some other manifestations such as nausea and vomiting may be felt before the occurrence of such events . Regular pelvic examination is recommended for some patients with the history of such cysts; they also may need regular sonography . Oral contraceptive pills (OCPs) are prescribed by some physician to shrink the cyst, if it is persistent and makes discomfort . Although it seems that they are not effective enough compared with close observation, and even some researchers reported no benefits for OCPs, some others prescribed them before any surgical practices ; therefore, the current study aimed at evaluating this issue. For this purpose, some patients who referred to a private clinic were selected in order to compare the effect of OCPs with close observation in the clinical management of functional ovarian cysts. dyspareunia, or the cysts may be found accidentally on voluntary sonography without any symptoms.

Being tested
Combined Oral Contraceptive, Progestin
Medical subject headings
Ovarian Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined Oral ContraceptiveDrug

    Also called cyclo progynova

    effect of cocs in treatment of ovarian cysts

  • ProgestinDrug

    Also called primalot-nor

    effect of progestin in treatment of ovarian cystn

Study groups in NCT05244811
Study groupRoleWhat they receive
use of placebo in treatment of functional ovarian cystPlacebo comparatortrial the effect of placebo in treatment of functional ovarian cyst
Receives: Drug: Combined Oral Contraceptive; Drug: Progestin
use of cocs in treatment of functional ovarian cystActive comparatortrial of the effectiveness of cocs in the treatment of functional ovarian cyst
Receives: Drug: Combined Oral Contraceptive; Drug: Progestin
use of progesterone in treatment of functional ovarian cystActive comparatorcomparison between the effect of progesterone in the treatment of functional ovarian cyst with the effect of cocs
Receives: Drug: Combined Oral Contraceptive; Drug: Progestin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. treatment of functional ovarian cysts

    rate of treatment of combined oral contraceptive pills in functional ovarian cyst compared with cases who will receive progesterone only pills

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2022
  2. Study start20 Feb 2022 (estimated)
  3. Primary completionJan 2023 (estimated)
  4. Study completionJan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05244811
Sponsor's protocol ID
ovarian cysts
Status last verified
Feb 2022
First submitted
9 Jan 2022
Last updated
17 Feb 2022
Results posted
No
FDA-regulated drug
Yes
FDA-regulated device
No

Publications

  • Formuso C, Stracquadanio M, Ciotta L. Myo-inositol vs. D-chiro inositol in PCOS treatment. Minerva Ginecol. 2015 Aug;67(4):321-5. Epub 2015 Feb 11.

    PubMed 25670222
  • Wu XK, Stener-Victorin E, Kuang HY, Ma HL, Gao JS, Xie LZ, Hou LH, Hu ZX, Shao XG, Ge J, Zhang JF, Xue HY, Xu XF, Liang RN, Ma HX, Yang HW, Li WL, Huang DM, Sun Y, Hao CF, Du SM, Yang ZW, Wang X, Yan Y, Chen XH, Fu P, Ding CF, Gao YQ, Zhou ZM, Wang CC, Wu TX, Liu JP, Ng EHY, Legro RS, Zhang H; PCOSAct Study Group. Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial. JAMA. 2017 Jun 27;317(24):2502-2514. doi: 10.1001/jama.2017.7217.

    PubMed 28655015

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Combined Oral Contraceptive and Progestin in people with Ovarian Neoplasms, run by Sohag University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact salah mohamed rasheed, professor (01224653702, salahrasheed67@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

treatment of functional ovarian cysts (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05244811, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in